Full text loading...
- ISSN: 1574-8871
- E-ISSN: 1876-1038
-
Anti-HER2 Therapy in Elderly Breast Cancer Patients
- Source: Reviews on Recent Clinical Trials, Volume 9, Issue 4, Dec 2014, p. 263 - 266
-
- 01 Dec 2014
Abstract
Targeting anti-HER-2 therapy, trastuzumab, Lapatinib, T-DM1, and Pertuzumab is a standard therapy for HER-2-overexpressing breast cancer. But there are less data available related to anti-HER-2 therapy in elderly patients because they have been consistently underrepresented in clinical trials. Anti- HER-2 therapy among an elderly population was reviewed including approaches for making treatment effective.
© Bentham Science Publishers